PAVmed Inc. (PAVM) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
360 MADISON AVENUE NEW YORK, NY 10017 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 19,639 | 39,744 | 77,258 | 17,256 | 6,219 | 8,222 | |||
| Cash and cash equivalents | 19,639 | 39,744 | 77,258 | 17,256 | 6,219 | 8,222 | |||
| Receivables | 61 | 17 | 200 | ||||||
| Inventory, net of allowances, customer advances and progress billings | 278 | ||||||||
| Inventory | 278 | ||||||||
| Prepaid expense | 848 | 300 | 1,856 | ||||||
| Other undisclosed current assets | 3,672 | 3,865 | 3,323 | 1,685 | 328 | 238 | |||
| Total current assets: | 24,498 | 43,926 | 82,637 | 18,941 | 6,548 | 8,460 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 4,267 | 3,037 | ✕ | ||||||
| Property, plant and equipment | 1,783 | 2,451 | 1,585 | 36 | |||||
| Long-term investments and receivables | |||||||||
| Long-term investments | |||||||||
| Intangible assets, net (including goodwill) | 1,424 | 3,445 | 2,029 | ||||||
| Intangible assets, net (excluding goodwill) | 1,424 | 3,445 | 2,029 | ||||||
| Other noncurrent assets | 1,147 | 1,121 | 725 | 837 | |||||
| Other undisclosed noncurrent assets | 693 | ||||||||
| Total noncurrent assets: | 8,621 | 10,054 | 4,339 | 837 | 693 | 36 | |||
| TOTAL ASSETS: | 33,119 | 53,980 | 86,976 | 19,778 | 7,240 | 8,496 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 6,626 | 3,705 | 4,259 | 2,325 | 3,740 | 3,070 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 3,151 | 1,777 | ||||
| Accounts payable | 1,786 | 2,704 | 2,353 | 1,739 | |||||
| Accrued liabilities | 6,626 | 3,705 | 1,387 | 1,331 | |||||
| Other undisclosed accounts payable and accrued liabilities | (1,786) | (2,704) | 1,108 | 548 | |||||
| Debt | 44,200 | 33,650 | 14,960 | 7,903 | |||||
| Other undisclosed current liabilities | 3,351 | 3,845 | 8,139 | ||||||
| Total current liabilities: | 54,177 | 41,200 | 4,259 | 17,285 | 11,879 | 10,973 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 2,960 | 1,846 | |||||||
| Operating lease, liability | 2,960 | 1,846 | ✕ | ||||||
| Total noncurrent liabilities: | 2,960 | 1,846 | |||||||
| Other undisclosed liabilities | 3,299 | 2,966 | |||||||
| Total liabilities: | 57,137 | 43,046 | 7,558 | 20,251 | 11,879 | 10,973 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (53,831) | (9,681) | 61,666 | 1,896 | (3,824) | (2,315) | |||
| Preferred stock | 2,993 | 2,695 | 2,419 | ||||||
| Common stock | 9 | 95 | 86 | 64 | 40 | 27 | |||
| Treasury stock, value | (408) | ||||||||
| Additional paid in capital | 237,600 | 216,106 | 198,071 | 87,570 | 47,554 | 32,619 | |||
| Accumulated deficit | (294,433) | (228,169) | (138,910) | (88,275) | (53,715) | (36,993) | |||
| Other undisclosed equity, attributable to parent | 2,537 | 2,296 | 2,032 | ||||||
| Equity, attributable to noncontrolling interest | 29,813 | 20,615 | 17,752 | (2,369) | (814) | (162) | |||
| Total equity: | (24,018) | 10,934 | 79,418 | (473) | (4,638) | (2,476) | |||
| TOTAL LIABILITIES AND EQUITY: | 33,119 | 53,980 | 86,976 | 19,778 | 7,240 | 8,496 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,500 | 377 | 500 | |||||
| Net investment income | 505 | |||||||
| Cost of revenue | (6,420) | (3,614) | (585) | |||||
| Gross profit: | (3,920) | (3,237) | (85) | |||||
| Operating expenses | (64,827) | (87,690) | (54,308) | (23,351) | (14,295) | (10,563) | ||
| Other undisclosed operating loss | (48) | |||||||
| Operating loss: | (68,795) | (90,927) | (54,393) | (23,351) | (14,295) | (10,563) | ||
| Nonoperating income (expense) | (10,468) | (12,311) | (1,733) | (12,537) | (2,973) | (7,610) | ||
| Investment income, nonoperating | ||||||||
| Other nonoperating expense | (10,468) | (12,311) | (1,733) | (12,537) | (2,973) | (7,610) | ||
| Interest and debt expense | (3,782) | (5,434) | (3,715) | (6,497) | 1,831 | (615) | ||
| Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | 6,497 | (1,831) | 615 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (83,045) | (108,672) | (59,841) | (35,888) | (17,268) | (18,173) | ||
| Other undisclosed income from continuing operations before income taxes | 3,782 | 5,434 | 3,715 | |||||
| Income (loss) from continuing operations before income taxes: | (79,263) | (103,238) | (56,126) | (35,888) | (17,268) | (18,173) | ||
| Income tax benefit | 18,937 | 8,718 | 8,150 | |||||
| Income (loss) from continuing operations: | (79,263) | (103,238) | (37,189) | (27,170) | (9,118) | (18,173) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (37,189) | (27,170) | (9,118) | (18,173) | |
| Other undisclosed net income (loss) | (18,937) | (8,718) | (8,150) | 18,377 | ||||
| Net income (loss): | (79,263) | (103,238) | (56,126) | (35,888) | (17,268) | 204 | ||
| Net income attributable to noncontrolling interest | 15,088 | 14,255 | 5,779 | 1,612 | 811 | 204 | ||
| Other undisclosed net loss attributable to parent | (18,377) | |||||||
| Net income (loss) attributable to parent: | (64,175) | (88,983) | (50,347) | (34,276) | (16,457) | (17,969) | ||
| Preferred stock dividends and other adjustments | (304) | (26) | ||||||
| Other undisclosed net loss available to common stockholders, basic | (1,791) | (281) | (283) | (287) | (270) | (756) | ||
| Net income (loss) available to common stockholders, diluted: | (66,270) | (89,264) | (50,630) | (34,563) | (16,727) | (18,751) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (79,263) | (103,238) | (56,126) | (35,888) | (17,268) | 204 | ||
| Comprehensive income (loss): | (79,263) | (103,238) | (56,126) | (35,888) | (17,268) | 204 | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 15,088 | 14,255 | 5,779 | 1,612 | 811 | 204 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (64,175) | (88,983) | (50,347) | (34,276) | (16,457) | 408 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.